Skip to search formSkip to main contentSkip to account menu

ouabagenin

Known as: 1 beta,3 beta,5,11 alpha,14,19- hexahydroxy-5 beta-card-20(22)-enolide, g-strophanthidin 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Ouabain
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
1998
1998
Detection of digitalis compounds using a surface plasmon resonance-based biosensor.
1996
1996
Endocytosis inhibition protects the isolated guinea pig heart against ouabain toxicity.
1993
1993
Amino acid residues of the Na,K-ATPase involved in ouabain sensitivity do not bind the sugar moiety of cardiac glycosides.
1991
1991
Identification of cysteine residues in lamb kidney (Na,K)-ATPase essential for ouabain binding.
1988
1988
Ouabain uptake by endocytosis in isolated guinea pig atria.
Mammalian cells specifically internalize some molecular species through receptor-mediated endocytosis (RME). We have used four… 
1988
1988
14β‐Hydroxyprogesterone binds to the digitalis receptor, inhibits the sodium pump and enhances cardiac contractility
1 Certain derivatives of progesterone are potent inhibitors of high affinity, specific binding of 3H‐cardiac glycosides. The… 
1986
1986
Identification of an essential sulfhydryl group in the ouabain binding site of (Na,K)-ATPase.
1986
1986
Involvement of (Na+ + K+)-ATPase in binding and actions of palytoxin on human erythrocytes.
Highly Cited
1980
Highly Cited
1980
A kinetic comparison of cardiac glycoside interactions with Na+,K+-ATPases from skeletal and cardiac muscle and from kidney.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)